Huntington National Bank’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31 Sell
1
-192
-99% -$6.05K ﹤0.01% 3213
2025
Q4
$5.69K Buy
+193
New +$5.36K ﹤0.01% 1960
2025
Q3
Sell
-40
Closed -$960 4193
2025
Q2
$960 Hold
40
﹤0.01% 2350
2025
Q1
$916 Sell
40
-478
-92% -$11.5K ﹤0.01% 2375
2024
Q4
$13.1K Buy
+518
New +$13.1K ﹤0.01% 1675
2024
Q3
Sell
-2,998
Closed -$88.9K 4206
2024
Q2
$88.9K Sell
2,998
-574
-16% -$15.9K ﹤0.01% 902
2024
Q1
$108K Buy
+3,572
New +$99.1K ﹤0.01% 870
2023
Q3
Sell
-50
Closed -$1.95K 3902
2023
Q2
$1.95K Buy
+50
New +$1.96K ﹤0.01% 2028

Other funds holding RTO

Huntington National Bank's RTO Position: Q1 2026 in Review

Huntington National Bank reduced its Rentokil (RTO) stake by 99% in Q1 2026, selling an estimated $6.05K and leaving 1 share worth $31. The position accounts for ﹤0.01% of the portfolio, ranked #3213.

Huntington National Bank first reported a position in RTO in Q2 2023 and has held it in 8 quarters since. The position peaked at $108K in Q1 2024. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Huntington National Bank held 1 share of Rentokil worth $31 as of Q1 2026.
  • Huntington National Bank sold 192 Rentokil shares in Q1 2026, an estimated $6.05K.
  • Rentokil made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3213 holding.
  • Huntington National Bank first reported a position in Rentokil in Q2 2023 and has held it in 8 quarters since.
  • Huntington National Bank's Rentokil position peaked at $108K in Q1 2024.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.